Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
Weight suppression appears to result in future onset of eating disorders characterized by dietary restriction or compensatory weight control behaviours, suggesting weight-suppressed women represent an at-risk group that may benefit from selective prevention programmes, a study has found.
Pearl Toh, 2 days ago
Quadrivalent human papillomavirus (HPV) vaccination can substantially reduce the risk of invasive cervical cancer, by up to almost 90 percent in women who were vaccinated early, a large Swedish registry-based study has shown.

CHD, mortality risks lower in women vs men following myocardial infarction

17 Oct 2020

Women appear to be substantially at lower risk of myocardial infarction (MI), coronary heart disease (CHD), and all-cause mortality than men following MI, suggests a recent study.

The authors analysed data for 171,897 women and 167,993 men aged 21 years with health insurance in the US who had MI hospitalization in 2015 or 2016. They matched MI patients by age and calendar year to 687,588 women and 671,972 men without CHD. Beneficiaries were followed until December 2017 for MI, CHD (ie, MI or coronary revascularization), and in Medicare for all-cause mortality.

Age-standardized rates of MI were 4.5 per 1,000 person-years (PY) in women and 5.7 per 1,000 PY in men without CHD (hazard ratio [HR], 0.64, 95 percent confidence interval [CI], 0.62–0.67) and 60.2 per 1,000 PY in women and 59.8 per 1,000 PY in men with MI (HR, 0.94, 95 percent CI, 0.92–0.96).

CHD rates were 6.3 in women compared with 10.7 in men without CHD (HR, 0.53, 95 percent CI, 0.51–0.54) and 84.5 vs 99.3, respectively, among those with MI (HR, 0.87, 95 percent CI, 0.85–0.89). Finally, rates of all-cause mortality were 63.7 in women compared with 59.0 in men without CHD (HR, 0.72, 95 percent CI, 0.71–0.73) and 311.6 vs 284.5, respectively, among those with MI (HR, 0.90, 95 percent CI, 0.89–0.92).

“Women have lower age-specific rates of incident CHD than men,” the authors noted.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
Weight suppression appears to result in future onset of eating disorders characterized by dietary restriction or compensatory weight control behaviours, suggesting weight-suppressed women represent an at-risk group that may benefit from selective prevention programmes, a study has found.
Pearl Toh, 2 days ago
Quadrivalent human papillomavirus (HPV) vaccination can substantially reduce the risk of invasive cervical cancer, by up to almost 90 percent in women who were vaccinated early, a large Swedish registry-based study has shown.